Recursion Pharmaceuticals Q4 EPS $(0.31) Up From $(0.38) YoY, Sales $13.68M Up From $2.53M YoY

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.31) per share. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year. The company reported $13.68 million in sales this quarter. This is a 439.91 percent increase over sales of $2.53 million the same period last year.